Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
23,263,283
-
Share change
-
-4,842,078
-
Total reported value
-
$14,312,893
-
Put/Call ratio
-
78%
-
Price per share
-
$0.57
-
Number of holders
-
48
-
Value change
-
-$5,863,612
-
Number of buys
-
21
-
Number of sells
-
23
Institutional Holders of NABRIVA THERAPEUTICS PLC - SHS as of Q1 2020
As of 31 Mar 2020,
NABRIVA THERAPEUTICS PLC - SHS was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,263,283 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, Aisling Capital Management LP, Vivo Capital, LLC, Rock Springs Capital Management LP, DIMENSIONAL FUND ADVISORS LP, Values First Advisors, Inc., SABBY MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
48
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.